Nextgen (NXGN) - Net Assets

Latest as of June 2025: ILA-9.72 Million ILA ≈ $-26.05K USD

Based on the latest financial reports, Nextgen (NXGN) has net assets worth ILA-9.72 Million ILA (≈ $-26.05K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA1.48 Million ≈ $3.97K USD) and total liabilities (ILA11.20 Million ≈ $30.02K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nextgen (NXGN) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA-9.72 Million
% of Total Assets -656.04%
Annual Growth Rate N/A
5-Year Change -135.89%
10-Year Change -242.07%
Growth Volatility 190.74

Nextgen - Net Assets Trend (2008–2024)

This chart illustrates how Nextgen's net assets have evolved over time, based on quarterly financial data. Also explore NXGN current and non-current assets for the complete picture of this company's asset base.

Annual Net Assets for Nextgen (2008–2024)

The table below shows the annual net assets of Nextgen from 2008 to 2024. For live valuation and market cap data, see Nextgen (NXGN) market capitalisation.

Year Net Assets Change
2024-12-31 ILA-2.46 Million
≈ $-6.61K
-151.79%
2023-12-31 ILA-979.00K
≈ $-2.62K
-107.99%
2022-12-31 ILA12.25 Million
≈ $32.84K
-40.84%
2021-12-31 ILA20.71 Million
≈ $55.51K
+201.49%
2020-12-31 ILA6.87 Million
≈ $18.41K
+486.01%
2019-12-31 ILA1.17 Million
≈ $3.14K
-50.92%
2018-12-31 ILA2.39 Million
≈ $6.40K
-34.72%
2017-12-31 ILA3.66 Million
≈ $9.81K
-28.74%
2016-12-31 ILA5.13 Million
≈ $13.76K
+195.85%
2015-12-31 ILA1.74 Million
≈ $4.65K
+296.27%
2014-12-31 ILA-884.00K
≈ $-2.37K
-358.48%
2013-12-31 ILA342.00K
≈ $916.89
-85.71%
2012-12-31 ILA2.39 Million
≈ $6.42K
-13.20%
2011-12-31 ILA2.76 Million
≈ $7.39K
-59.93%
2010-12-31 ILA6.88 Million
≈ $18.45K
+43.39%
2008-12-31 ILA4.80 Million
≈ $12.86K
--

Equity Component Analysis

This analysis shows how different components contribute to Nextgen's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 7094200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components ILA68.60 Million %
Total Equity ILA-2.34 Million 100.00%

Nextgen Competitors by Market Cap

The table below lists competitors of Nextgen ranked by their market capitalization.

Company Market Cap
Ngenic AB
ST:NGENIC
$1.53 Million
GGX Gold Corp
V:GGX
$1.53 Million
GEMINA LABS LTD
F:8I7
$1.53 Million
CanadaBis Capital Inc
V:CANB
$1.53 Million
CBEYOND
F:C5B
$1.52 Million
Pineapple Financial Inc.
NYSE:PAPL
$1.52 Million
Im Cannabis Corp
NASDAQ:IMCC
$1.52 Million
Creative Eye Limited
NSE:CREATIVEYE
$1.52 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nextgen's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -860,000 to -2,341,000, a change of -1,481,000.
  • Net loss of 4,892,000 reduced equity.
  • New share issuances of 2,140,000 increased equity.
  • Other comprehensive income decreased equity by 7,036,000.
  • Other factors increased equity by 8,307,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ILA-4.89 Million -208.97%
Share Issuances ILA2.14 Million +91.41%
Other Comprehensive Income ILA-7.04 Million -300.56%
Other Changes ILA8.31 Million +354.85%
Total Change ILA- %

Book Value vs Market Value Analysis

This analysis compares Nextgen's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 ILA0.13 ILA52.20 x
2014-12-31 ILA-0.24 ILA52.20 x
2015-12-31 ILA0.24 ILA52.20 x
2016-12-31 ILA0.27 ILA52.20 x
2017-12-31 ILA0.13 ILA52.20 x
2018-12-31 ILA0.09 ILA52.20 x
2019-12-31 ILA0.04 ILA52.20 x
2020-12-31 ILA0.21 ILA52.20 x
2021-12-31 ILA0.52 ILA52.20 x
2022-12-31 ILA0.29 ILA52.20 x
2023-12-31 ILA-0.12 ILA52.20 x
2024-12-31 ILA-0.28 ILA52.20 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nextgen utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-229.28%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 -2191.20% 0.00% 0.00x 3.67x ILA-8.25 Million
2014 0.00% 0.00% 0.00x 0.00x ILA-4.85 Million
2015 -238.95% 0.00% 0.00x 1.36x ILA-4.51 Million
2016 -34.64% 0.00% 0.00x 1.15x ILA-2.33 Million
2017 -39.98% 0.00% 0.00x 1.16x ILA-1.87 Million
2018 -50.87% 0.00% 0.00x 1.25x ILA-1.51 Million
2019 -95.52% 0.00% 0.00x 1.52x ILA-1.34 Million
2020 -18.60% 0.00% 0.00x 1.19x ILA-1.99 Million
2021 -12.25% 0.00% 0.00x 1.14x ILA-4.63 Million
2022 -69.35% 0.00% 0.00x 1.20x ILA-9.81 Million
2023 0.00% 0.00% 0.00x 0.00x ILA-14.11 Million
2024 0.00% 0.00% 0.00x 0.00x ILA-4.66 Million

Industry Comparison

This section compares Nextgen's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $80,869,667
  • Average return on equity (ROE) among peers: 12.06%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nextgen (NXGN) ILA-9.72 Million -2191.20% N/A $1.53 Million
Batm Advanced Communications Ltd (BVC) $114.00 Million 0.21% 0.54x $51.06 Million
Nissan (NISA) $129.84 Million 35.97% 2.73x $19.06 Million
Storage Drop Storage Technologies Ltd (STRG) $-1.23 Million 0.00% 0.00x $614.25K

About Nextgen

TA:NXGN Israel Medical Instruments & Supplies
Market Cap
$1.53 Million
ILA569.04 Million ILA
Market Cap Rank
#29915 Global
#442 in Israel
Share Price
ILA52.20
Change (1 day)
+0.00%
52-Week Range
ILA37.60 - ILA70.00
All Time High
ILA25020.00
About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.